223 related articles for article (PubMed ID: 26130736)
1. Renal impairment in patients with polyneuropathy, organomegaly, endocrinopathy, monoclonal gammopathy and skin changes syndrome: incidence, treatment and outcome.
Ye W; Wang C; Cai QQ; Cai H; Duan MH; Li H; Cao XX; Zhou DB; Li J
Nephrol Dial Transplant; 2016 Feb; 31(2):275-83. PubMed ID: 26130736
[TBL] [Abstract][Full Text] [Related]
2. Living with Polyneuropathy Organomegaly Endocrinopathy Monoclonal gammopathy Skin changes (POEMS) syndrome: a case study of healthcare experiences and quality of life.
Twigg J; Methley A; Lavin T; Dickinson G; Teager A
Disabil Rehabil; 2021 Aug; 43(17):2502-2510. PubMed ID: 31838877
[TBL] [Abstract][Full Text] [Related]
3. Plasma-cell dyscrasia with polyneuropathy. The spectrum of POEMS syndrome.
Miralles GD; O'Fallon JR; Talley NJ
N Engl J Med; 1992 Dec; 327(27):1919-23. PubMed ID: 1333569
[TBL] [Abstract][Full Text] [Related]
4. Clinical characteristics and the long-term outcome of patients with atypical POEMS syndrome variant with undetectable monoclonal gammopathy.
He T; Zhao A; Zhao H; Cai H; Feng J; Zhang L; Cao X; Zhou D; Li J
Ann Hematol; 2019 Mar; 98(3):735-743. PubMed ID: 30612232
[TBL] [Abstract][Full Text] [Related]
5. A prospective phase II study of low dose lenalidomide plus dexamethasone in patients with newly diagnosed polyneuropathy, organomegaly, endocrinopathy, monoclonal gammopathy, and skin changes (POEMS) syndrome.
Li J; Huang XF; Cai QQ; Wang C; Cai H; Zhao H; Zhang L; Cao XX; Gale RP; Zhou DB
Am J Hematol; 2018 Jun; 93(6):803-809. PubMed ID: 29603764
[TBL] [Abstract][Full Text] [Related]
6. Impact of pretransplant induction therapy on autologous stem cell transplantation for patients with newly diagnosed POEMS syndrome.
Li J; Duan MH; Wang C; Huang XF; Zhang W; Cao XX; Zhu TN; Zhuang JL; Han B; Cai H; Cai HC; Zhou DB
Leukemia; 2017 Jun; 31(6):1375-1381. PubMed ID: 28100909
[TBL] [Abstract][Full Text] [Related]
7. Prognostic study for overall survival in patients with newly diagnosed POEMS syndrome.
Wang C; Huang XF; Cai QQ; Cao XX; Duan MH; Cai H; Zhou DB; Li J
Leukemia; 2017 Jan; 31(1):100-106. PubMed ID: 27338259
[TBL] [Abstract][Full Text] [Related]
8. Skin Responses in Newly Diagnosed Polyneuropathy, Organomegaly, Endocrinopathy, Monoclonal Gammopathy, and Skin Changes (POEMS) Syndrome After Therapy With Low-Dose Lenalidomide Plus Dexamethasone.
Gao Y; Zhang S; Yang L; Li J; Liu Y; Wang T
Front Immunol; 2021; 12():681360. PubMed ID: 34025681
[TBL] [Abstract][Full Text] [Related]
9. Surgical revascularization for quasi-moyamoya disease associated with polyneuropathy, organomegaly, endocrinopathy, monoclonal gammopathy, and skin changes (POEMS) syndrome: a case report and literature review.
Kubota Y; Hanaoka Y; Koyama JI; Takahashi Y; Katoh N; Iwaya M; Fujii Y; Ogiwara T; Horiuchi T
Nagoya J Med Sci; 2023 Feb; 85(1):141-149. PubMed ID: 36923610
[TBL] [Abstract][Full Text] [Related]
10. Clinical characteristics and long-term outcome of patients with POEMS syndrome in China.
Li J; Zhou DB; Huang Z; Jiao L; Duan MH; Zhang W; Zhao YQ; Shen T
Ann Hematol; 2011 Jul; 90(7):819-26. PubMed ID: 21221584
[TBL] [Abstract][Full Text] [Related]
11. POEMS syndrome: definitions and long-term outcome.
Dispenzieri A; Kyle RA; Lacy MQ; Rajkumar SV; Therneau TM; Larson DR; Greipp PR; Witzig TE; Basu R; Suarez GA; Fonseca R; Lust JA; Gertz MA
Blood; 2003 Apr; 101(7):2496-506. PubMed ID: 12456500
[TBL] [Abstract][Full Text] [Related]
12. POEMS Syndrome with Biclonal Gammopathy and Renal Involvement.
Inoue K; Nagai K; Tsukada T; Iwase M; Sakata A; Ueda A; Yamagata K
Intern Med; 2022 Jul; 61(14):2191-2196. PubMed ID: 35283379
[TBL] [Abstract][Full Text] [Related]
13. POEMS syndrome (polyneuropathy, organomegaly, endocrinopathy, monoclonal gammopathy, and skin changes).
Liang C; Gonzalez M; Patel R; Meehan S; Kamino H; Franks AG
Dermatol Online J; 2009 Aug; 15(8):9. PubMed ID: 19891917
[TBL] [Abstract][Full Text] [Related]
14. Polyneuropathy improvement following autologous stem cell transplantation for POEMS syndrome.
Karam C; Klein CJ; Dispenzieri A; Dyck PJ; Mandrekar J; D'Souza A; Mauermann ML
Neurology; 2015 May; 84(19):1981-7. PubMed ID: 25878176
[TBL] [Abstract][Full Text] [Related]
15. POEMS syndrome (polyneuropathy, organomegaly, endocrinopathy, monoclonal gammopathy and skin changes) treated with autologous hematopoietic stem cell transplantation: a case report and literature review.
Arana C; Pérez de León JA; Gómez-Moreno G; Pérez-Cano R; Martín Hernández T
Am J Case Rep; 2015 Mar; 16():124-9. PubMed ID: 25726020
[TBL] [Abstract][Full Text] [Related]
16. Vascular endothelial growth factor as a predictive marker for POEMS syndrome treatment response: retrospective cohort study.
Misawa S; Sato Y; Katayama K; Hanaoka H; Sawai S; Beppu M; Nomura F; Shibuya K; Sekiguchi Y; Iwai Y; Watanabe K; Amino H; Ohwada C; Takeuchi M; Sakaida E; Nakaseko C; Kuwabara S
BMJ Open; 2015 Nov; 5(11):e009157. PubMed ID: 26560063
[TBL] [Abstract][Full Text] [Related]
17. Prevalence and Course of Endocrinopathy in POEMS Syndrome.
Caimari F; Keddie S; Lunn MP; D'Sa S; Baldeweg SE
J Clin Endocrinol Metab; 2019 Jun; 104(6):2140-2146. PubMed ID: 30239770
[TBL] [Abstract][Full Text] [Related]
18. Sequential changes in renal function and the risk of stroke and death in patients with atrial fibrillation.
Guo Y; Wang H; Zhao X; Zhang Y; Zhang D; Ma J; Wang Y; Lip GY
Int J Cardiol; 2013 Oct; 168(5):4678-84. PubMed ID: 23972369
[TBL] [Abstract][Full Text] [Related]
19. Prevalence and risk factors for depression in newly diagnosed patients with POEMS syndrome.
Zhang L; Zhou YL; Zhang W; Duan MH; Cao XX; Zhou DB; Li J
Leuk Lymphoma; 2014 Dec; 55(12):2835-41. PubMed ID: 24524304
[TBL] [Abstract][Full Text] [Related]
20. Bortezomib plus dexamethasone as first-line therapy for patients with POEMS syndrome.
Gao XM; Yu YY; Zhao H; Cai H; Zhang L; Cao XX; Zhou DB; Li J
Ann Hematol; 2021 Nov; 100(11):2755-2761. PubMed ID: 34331562
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
